Backgrounds/Aims: The aim of this retrospective study is to compare stomach cancer incidence, characteristics between gallstones, cholecystectomy and control groups. It also aims to investigate key variables' potential effects on overall survival. Methods: A total of 99 patients, diagnosed with stomach cancers between April 1994 and December 2015, were identified. We excluded stomach cancer patients, accrued during the first year of follow-up in both the gallstones and cholecystectomy groups, assuming that they missed cancers. The main analyses addressing the objective were a chi-square analysis and a survival analysis. Results: The incidence of stomach cancers was increased in both the gallstone and cholecystectomy groups, compared with the control group (p=0.003). Multivariate regression analysis showed that the overall survival in gallstones, cholecystectomy group patients as compared with those in the control group decreased (HR=6.66, 95 CI: 1. 94-22.80, p=0.003). Also, T-stage was found to statistically affect the rate of overall survival (HR=9.85, 95% CI: 3.09-31.39, p=.000). The stomach cancer showed the worse survival at the posterior, greater curvature location than anterior, lesser curvature of the stomach. (HR=0.30, 95% CI: 0.11-0.80, p=0.017). Conclusions: We provided an awareness of the possible increased risks of stomach cancer in gallstone and cholecystectomy group patients, which might be induced by duodenogastric bile reflux. Also, the survival rate was poor (p＜0.000). Therefore, close follow-up strategies for early detection are recommended for such patients. 
INTRODUCTION
Gallstone disease poses significant health problems. In Asia, westernization of the diet and socioeconomic status have changed the patterns of gallstone disease. 1 Cholecystectomy is the treatment of choice for symptomatic gallstones. After the adoption of noninvasive laparoscopic cholecystectomy, the number of cholecystectomies has increased worldwide. Stomach cancer is the fifth most common cancer in the world-and the highest incidences have been in East Asia, China, Eastern Europe, Latin America, and the Caribbean. 2 In healthy individuals, 75-80% of hepatic bile enters the gallbladder and only 20-25% of bile directly enters into the duodenum. In cases of chronic calculous cholecystitis, 30-40% of hepatic bile enters the gallbladder and 60-70% of hepatic bile passes into the duodenum (due to the decreased rate of water absorption in the gallbladder wall). Following cholecystectomy, 100% of the hepatic bile enters the duodenum (Fig. 1) . 3 During the process of enterohepatic circulation, anaerobic bacteria promote 7-dehydroxylation of hydrophilic primary bile acids (cholic acid and chenodeoxycholic acid), converting them into hydrophobic secondary bile acids (deoxycholic acid [DCA] and lithocholic acid).
Depending on the concentration, hydrophobic secondary bile acids can cause cholestasis and necrosis or promote apoptosis and DNA damage. Furthermore, DCA is not only mutagenic but carcinogenic. Taken together, the evidence suggests that the human gallbladder fulfills a protective function. The gallbladder decreases the formation of secondary hydrophobic hepatotoxic bile acids by accumulating primary bile acids thereby, protecting the liver and the mucosa of the stomach. 4 Based on the biological mechanism described above, we hypothesized that gallstones, cholecystectomy would be associated with an increased risk of stomach cancers, and evaluated the association of gallstones, cholecystectomy with stomach cancer in a hospital-based case-control study.
MATERIALS AND METHODS

Study sample
A total of 99 patients newly diagnosed with stomach cancers were enrolled in this study. Between April 1994
and December 2015, we identified 5,566 patients whose records contained a cholecystectomy code (International Classification of Disease, Ninth Revision). The gallstones group consisted of 6,891 patients who had a diagnosis of gallstones and were not cholecystectomized.
To reduce the effect of selection bias, we excluded stomach cancers, which appeared during the first year of follow-up either cholecystectomy or after a diagnosis of non-surgically-treated gallstones. This was done for the detection of stomach cancer cases identified only because of gallstones and cholecystectomy.
Control patients who voluntarily visited the Dong-A University Hospital Health Care System, for a health check-up between June 2007 and December 2015 were enrolled. As a part of these health care programs, patients were routinely screened with ultrasonography. Of the 37,236 initially enrolled patients, 2,525 foreign patients or gallstone patients were excluded. Therefore, 34,711 control patients were included in this analysis. We retrospectively reviewed the patient's medical records.
Immunohistochemical studies
Immunohistochemical chemistry was used as diagnostic aids, prognostic or predictive indicators, or histogenetic probes. The p53 protein was detected for genomic stability. CD10 and MUC2 mucin were used as biomarkers for the identification of intestinal metaplasia.
MUC5AC and MUC6 mucins were used as biomarkers for the identification of gastric goblet epithelium. CD31 was used as a biomarker for the identification of endothelial cells.
Endoscopic finding
We determined the level of each stomach cancer 
Statistical analysis
Variables were summarized by frequency and percentage for the categorical data. A mean±standard test or Fisher's exact test was used for categorical data. An independent t-test was used for numeric data. Overall survival (OS) was estimated using Kaplan-Meier curves.
Survival curves were compared between groups using the log-rank test. Multivariate analyses, using Cox regression, were performed in order to identify prognostic factors, which are independently related to overall survival.
All statistical analyses were carried out using SPSS 22.0 (IBM Corp., Armonk, NY) and MedCalc 11.6.0 (MedCalc, Mariakerke, Belgium) statistical software. P values of less than 0.05 were considered to be statistically significant. By its nature, this study was explorative.
Therefore, no adjustment for multiple testing was applied.
RESULTS
The demographic characteristics of stomach cancers are were older than those in the control group (p=0.000). The median follow-up time was 53 months. The overall incidence rate of stomach cancer was higher in the gallstone and cholecystectomy groups than in the control group (p=0.003) (Fig. 2) .
The median overall survival rate was shown to be worse in the gallstone and cholecystectomy group than in the control group (p=0.000) (Fig. 3) .
The prevalence of comorbidities-especially hypertension and cerebrovascular comorbidities-was greater in Fig. 2 . Comparison of stomach cancer incidence between the groups. GB( ), cholecystectomy; GB(+), gallstones. 
DISCUSSION
The association of the gallstone and cholecystectomy group patients with stomach cancer suggests that exposure to bile may be an important carcinogenic mechanism. In the gallstone and cholecystectomy groups, the overall incidence of stomach cancer was higher in this study's series-a finding which was consistent with other results.
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By contrast, other studies yielded data that conflicted with these results. 8, 9 The burdensome challenge of the prevalence of gallstones in western countries (ranging from 5.9% to 21.9% in the general population) has increasingly become a problem. A genetic link to cholesterol (30% of the genetic component being accounted for by "thrifty" genes) has been postulated and the associations among diabetes, obesity, and gallstones most likely come about through the metabolic syndrome. 10 There has been a gradual increase in the incidence of gallstones in conjunction with the westernization of The question of whether prophylactic cholecystectomy during gastrectomy for cancers is needed remains a controversial issue. The reason for prophylactic cholecystectomy is the incidence of gallstones after gastrectomy was considerably higher than was the prevalence of gallstones detected during the health examination in Korea (2.3-4.9%). 25, 26 The main pathophysiologic mechanism is considered to be an interruption of the anterior hepatic branch of the vagus nerve-a condition which leads to bile juice stagnation. So, is prophylactic cholecystectomy needed? On the contrary, after gastrectomy, most patients-at least 75%-will not have gallstone disease and may possibly experience a functional digestive problem as a result of unnecessary cholecystectomy having been performed. 27 Our results lend some support to the decision to avoid prophylactic cholecystectomy for the risk of stomach cancer, if indication for the surgery is uncertain.
This study provides more compelling results than do previous studies. Firstly, this study is a large-scale, hospital-based, case-control study. This study was based on a control group representative of the general population (considering the nature of the health screenings).
Secondly, this study is not merely an epidemiological study, but a clinical study based on endoscopic findings, imaging results, immunohistochemical tests, and survival analyses for members of the Asian population. However, there are some limitations of this study. Firstly, the case-control design is more susceptible to recall and selection bias than is a cohort design. Secondly, retrospective studies such as this one generally tend to be lower in statistical quality than the findings of randomized controlled trials.
In conclusion, we suggest that there sould be an awareness of the possibility of an increased risk for developing stomach cancer in gallstones, cholecystectomy patients, which might be induced by duodenogastric bile reflux.
Moreover, as the characteristics of the stomach cancers were only detected once they had already progressed to an advanced stage, the survival rate was worse than for those in the control group. Therefore, close follow-up strategies for the early detection of stomach cancer are recommended in caring for these patients. Further studies are needed regarding the linkage between gallstones, chol-
